Advanced head and neck cancer: Long-term results of chemo-radiotherapy, complications and induction of second malignancies

Onkologie

Volumn 24, Issue 6, 2001, Pages 553-558

  Munker, R ^a   Purmale, L ^a   Aydemir, U ^c   Reitmeier, M ^a   Pohlmann, H ^a   Schorer, H ^b   Hartenstein, R ^a  

^a IV Medizinische Abteilung (Tumorzentrum)   (Germany)

^b Munich Municipal Hospital   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Chemo radiotherapy; Head and Neck Cancer; Late effects; Second malignancies

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CANNULATION; COLON CANCER; CONTROLLED STUDY; DRUG INDUCED DISEASE; FEMALE; FIBROSIS; HEAD AND NECK CANCER; HIGH RISK POPULATION; HUMAN; IATROGENIC DISEASE; LONG TERM CARE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NERVE LESION; POPULATION; PROGNOSIS; QUALITY OF LIFE; SECOND CANCER; SKIN CANCER; SURVIVAL TIME; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COBALT RADIOISOTOPES; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM STAGING; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; OTORHINOLARYNGOLOGIC NEOPLASMS; RADIATION INJURIES; RADIOISOTOPE TELETHERAPY; SURVIVAL RATE;

EID: 0035698278     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000055143     Document Type: Article

References (31)

1. Simultaneous chemo-radiotherapy with 5-FU/folinic acid/cis-platinum and accelerated split-course radiation in advanced head and neck cancer
2. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study
3. Concurrent chemoradiation for head and neck cancer, ASCO 36
4. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data
5. Second malignant neoplasms: Clinical implications and basic research
6. Multiple primary cancer of the head and neck, esophagus, and lung
7. Synchronous and metachronous head and neck carcinomas
8. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck
9. Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck
10. Second malignancies after Hodgkin's disease: The Munich experience
11. Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: Results of the Yale mitomycin randomized trials
12. Hyperfraktionierte-akzelerierte simultane radio-chemotherapie bei fortgeschrittenen hypopharynxkarzinomen
13. Pattern of failure in long-term survivors after radio-chemotherapy for inoperable head and neck cancer
14. Therapy-related malignancies following treatment of germ cell cancer
15. Second malignancies in patients who have head and neck cancer: Incidence, effect on survival and implications based on the RTOG experience
16. Second primary malignancies in the head and neck cancer patient
17. Second primary tumors in patients with head and neck squamous cell carcinoma
18. Second neoplasms in patients with head and neck cancer
19. A randomized trial of combined multidrug chemotherapy and radiotherapy in advanced squamous cell carcinoma of the head and neck
20. Simultaneous radiochemotherapy in the treatment of inoperable, locally advanced head and neck cancers. A single-institution study
21. Chemo-radiotherapy for locally advanced head and neck cancer - Long-term results of a phase II trial
22. Hyperfractionated radiation therapy and 5-fluorouracil, cis-platin, and mitomycin-C (± granulocyte-colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma
23. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer
24. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer
25. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: A prospective randomized trial
26. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma
27. Second esophageal tumors in patients with head and neck squamous cell carcinoma: An assessment of clonal relationships
28. Preliminary oncological results of a multimodality regimen with transoral laser surgery, neck dissection and postoperative irradiation in advanced laryngeal carcinomas
29. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: A prospective examination
30. Health-related quality of life in long-term head and neck cancer survivors: A comparison with general population norms
31. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer